酶激活的核心外药物共晶纳米颗粒用于向的沙门氏清除和肠道微生物群恢复
Siying Huang1,2, Tingting Wang1,2, Nuo Sheng1,2
1Sanya Institute of China Agricultural University, Sanya, 572025, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|October 14, 2025
概括
一个新的纳米粒子平台有效地准肠道中的沙门氏菌 Typhimurium 感染. 这种创新方法提高了抗生素的输送和疗效,改善了细菌肠道感染的治疗结果.
科学领域:
- 微生物学 微生物学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 沙门氏菌 Typhimurium 导致肠道感染和结肠炎,由于口服抗生素有效性有限,造成临床挑战.
- 主体屏障限制了传统口服抗生素对沙门氏菌等肠道病原体的疗效.
研究的目的:
- 开发一个创新的纳米粒子平台,用于向的沙门氏菌Typhimurium治疗.
- 提高口服抗生素的生物可用性和有效性,用于细胞内肠道感染.
主要方法:
- 合成PC@Kana@TA纳米颗粒 (NP) 通过自组装酸 (TA) 和胺素 (Kana),然后涂上pectin-chitosan (PC) 涂层.
- 采用双层涂层,以抵抗胃酸和对pectinase敏感的肠道释放.
- 在RAW264.7和Caco-2细胞中评估了体内细胞内沙门氏菌清除率.
主要成果:
- PC@Kana@TA NPs证明了药物稳定性和杀菌功效的提高.
- 在实验室中达到70%以上的细胞内沙门氏菌清除.
- 在体内研究表明,光线沙门氏菌减少了5-log,并恢复了炎症性细胞因子水平.
- 与卡纳米辛组相比,有益的肠道细菌的数量增加了30.53%.
结论:
- 开发的纳米粒子平台为纳米启用细胞内感染疗法提供了一种多功能策略.
- 这种方法提高了口服生物可用性和治疗沙门氏菌Typhimurium的疗效.
- 在治疗肠道感染方面,为抗生素重新定位和优化提供了新的机会.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
196
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
196
Bioavailability Enhancement: Drug Solubility Enhancement
221
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
221
Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
423
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
423


